In Q4, Life Insurance Corporation (LIC) reduced its holdings, selling off significant shares of HDFC Bank and SBI among their top 10 stock disposals. This notable divestment was reported by ETMarkets.

After steady performances, Life Insurance Corporation (LIC) adjusts its valuation to 'fair' from 'very attractive'. Investors are reconsidering the company's P/E and P/BV ratios, comparing them with both historical benchmarks and industry peers.

Investors are optimistic about ONGC's Q4 earnings as Morgan Stanley expresses a positive outlook for the Maharatna PSU stock, indicating potential growth ahead.

Man Industries reports a 25% drop in Q4 net profit, with earnings down to INR 509 million compared to last year. Additionally, revenue decreased by about 5%, reaching INR 11.5 billion for the same period.

Torrent Pharma reached an unprecedented high of Rs 4,698.8 on May 25, 2026, surpassing previous records. The stock demonstrated robust performance, outpacing the Sensex and exhibiting positive momentum over various time periods.

Elara Capital maintains a positive outlook for Zydus Lifesciences, predicting its stock to reach ₹1,311, encouraging investors to consider buying shares.

Leading companies saw significant growth: Reliance surged by ₹24,697 crore, boosting the combined market capitalization by ₹74,111 crore. ICICI Bank and TCS registered gains, but Bharti Airtel and SBI faced valuation decreases amidst market volatility.

Manoj Vaibhav's Q4 net profit increased by 7% year-over-year, reaching ₹280 million, while total revenue for the same period climbed up to ₹7.5 billion, marking a 5% growth compared to last year.

The stock of Sundrop Brands Ltd has been downgraded from 'Hold' to 'Sell', indicating a potential risk due to its high valuation relative to the industry average, despite only moderate price increases. Investors may want to exercise caution with this stock.

Sandhar Tech's Q4 earnings show a significant surge in profits by nearly 50%, while revenues grew by around 29% compared to last year, indicating strong financial performance for the company.

Bikaji Foods has reported a substantial increase in Q4 EBITDA by almost four times year-over-year, accompanied by a profit growth of 26.2%. The company announced a dividend of ₹1.25 per share and appointed Deepak Agarwal as its new Chairman, effective from May 21st.

ET Now anticipates Hindalco's Q4 FY26 earnings, suggesting potential profit growth driven by strong aluminum and copper demand.

Shares of defense companies BEL, HAL, BDL, and Mazagon Dock see a boost due to rumors of an impending BrahMos export deal, indicating potential growth in international sales for these companies.

In the year 2026, mid-cap and small-cap stocks have been the standouts, with the Nifty Smallcap 100 and Nifty Midcap 100 indices showing gains of 1.5% and 1.3% YTD respectively. Notable performers in this space are HFCL (up 112.8%), BSE (up 58.7%), SAIL (up 33.5%), and Apar Industries (up 53.5%).

Tata Communication's shares have increased due to management changes and new strategic plans, as suggested by brokerage analysts, with Janhavi Ladda providing insightful perspectives in this regard.

Nykaa shares witnessed volatility after impressive earnings, closing 0.6% lower at Rs. 272.85, having previously reached a 52-week high of Rs. 285.6. Analyst opinions diverge, with Jefferies advocating a buy at Rs. 350 and Citi recommending a sell due to valuation concerns at a multiple of 67x FY28 EV/EBITDA.

Apollo Hospitals aims to expand operations and enhance its clinical expertise in order to maintain its leading position within the healthcare sector.

Investors should brace for a potential 35% decline in Ola Electric's share price following the release of their Q4 results, according to Emkay's recent warning.

Investment advisory JM Financial has downgraded Zydus Lifesci to 'Reduce', suggesting potential decreased performance at the current share price of ₹1,040.95.

DAM Capital maintains a sell recommendation for PI Industries, predicting a target price of ₹2556. This decision is based on challenges in the Agchem sector and weak domestic demand, leading to reduced EPS projections for FY27/FY28 due to slow growth. Additionally, the company anticipates margin pressure due to increased costs and R&D expenditure.

JNK India's Q4 EBITDA has significantly increased by approximately 180% year-over-year, reaching ₹420M. The company's profit margin also doubled, now standing at 14%.

Honeywell has announced that Satish Agarwal will take on the role of Chief Financial Officer starting June 1, 2026. Meanwhile, the current internal auditor is stepping down, effective August 1, 2026, and their contributions are acknowledged and appreciated.

Grasim surpasses expectations in Q4, driven by impressive VSF performance, signaling continued growth potential. Mankind Pharma exhibits strong domestic expansion, while Jubilant Food faces margin challenges. Apollo Hospitals receives mixed reviews due to valuation concerns, but a positive outlook following AB Capital's equity raise.

JK Cement secures the Itauri-Jharkua limestone block mining lease in Madhya Pradesh, enhancing their resource supply for cement production.

Bajaj Auto has contributed to an increase in KTM's profitability for Q1 of this year, demonstrating a successful partnership between the two companies.

Emmbi Industries will present their audited financial year 2026 results during a board meeting on May 25, 2026. The meeting could potentially include discussions regarding potential dividend payouts, and the trading window is expected to reopen following the meeting's conclusion.

Associated Alcohols saw a significant increase in IMFL volume by 37% year-over-year, with a notable spike of 129% in ENA sales. Despite a slight 2% drop in overall revenue to ₹2,385 million, the profit after tax (PAT) increased by 5%.

Today's stock market focus includes Lenskart, Apollo Hospitals, ZEE, BPCL, and Hindalco. The attention is due to recent news updates and the upcoming Q4 results, which could potentially influence their stock performance.

HealthCare Global has reported a significant increase in revenue for FY26, up 15% year-over-year at approximately INR 25.45 billion. The company also showed a strong improvement in profitability, with adjusted EBITDA climbing by 19% to INR 4.71 billion and maintaining an impressive margin of 18.5%.

Aurobindo Pharma's options interest climbed by 19.8%, suggesting a positive trend in the pharmaceutical industry, with over 55,000 contracts traded. This surge in volume and price action could be a sign of growing optimism among investors in this sector.

Emkay has suggested buying Genus Power Infra shares, setting a target price of ₹550. This recommendation indicates a potential increase of approximately 78.6% in the stock's value.

Bel FY21 Q4 profits have increased by 5%. For detailed dividend information, kindly refer to the linked source.

Top picks for today (May 19) feature companies like IGL, Paytm, Power Grid, KEC Intl, NHPC, and Bajaj Finance. Analysts suggest potential investment strategies, ranging from buying, selling, or holding these stocks, as per ET NOW.

Bajaj Auto's subsidiary has made an early repayment of $80 million in loans, owed to JP Morgan and DBS, as part of the KTM AG restructuring process. The full loan repayment was scheduled for May 2026 but has been brought forward.

Zydus Life has authorized a buyback of nearly 96 million shares at ₹1,150 each, with the promoters participating. In Q4, the company reported impressive results, including a net profit of ₹1,272.5 crore and EBITDA margin of 33.7%, despite revenue reaching ₹7,587 crore.

Kolte-Patil Developers is set to disclose their Q4 and FY26 financial results at an upcoming board meeting on May 22nd, 2026. The meeting will also explore potential fundraising strategies through equity, NCDs, bonds, GDRs, ADRs, or alternative instruments.

The NiftyBank index has dropped significantly today due to a 3% decline in shares of major players like PNB, Canara Bank, and SBI. This suggests ongoing worries about the banking sector's overall performance and potential market direction.

Strides Pharma's Q4 profits experienced a significant increase, jumping 55% year-over-year to reach approximately INR 1.27 billion compared to the previous year's INR 822 million.

Neuland Labs reported a remarkable 135% revenue growth in Q4FY26, reaching ₹788.7 crore. Overall FY26 revenue increased by 37%. The EBITDA margin improved significantly in Q4FY26 to 40.5%, compared to 29.4% in FY26. However, the company faced a negative free cash flow of ₹49.4 crore due to higher working capital requirements.

Ambuja Cements has announced a reduction in its capital expenditure for FY27, aiming to invest between 6,000-6,500 crores compared to the initial 7,500 crores. The decision comes as the company prioritizes completing ongoing projects due to delays in expansion implementation.